Yang Yu Min Yu Yanying Li Xiaojuan Zhou Tian Tian Yijia Du Zegui Tu Meijuan Huang
10.3389/fonc.2022.945620
Front Oncol
2022 Aug 19;12:945620.
braf fusion mapk pathway sdn1-braf lung adenocarcinoma trametinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/36059688/
Case Reports
PMC9437588
36059688
Rapid response to monotherapy with MEK inhibitor trametinib for a lung adenocarcinoma patient harboring primary SDN1-BRAF fusion: A case report and literature review
2022